IMB1_HUMAN - dbPTM
IMB1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID IMB1_HUMAN
UniProt AC Q14974
Protein Name Importin subunit beta-1
Gene Name KPNB1
Organism Homo sapiens (Human).
Sequence Length 876
Subcellular Localization Cytoplasm . Nucleus envelope .
Protein Description Functions in nuclear protein import, either in association with an adapter protein, like an importin-alpha subunit, which binds to nuclear localization signals (NLS) in cargo substrates, or by acting as autonomous nuclear transport receptor. Acting autonomously, serves itself as NLS receptor. Docking of the importin/substrate complex to the nuclear pore complex (NPC) is mediated by KPNB1 through binding to nucleoporin FxFG repeats and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to importin-beta and the three components separate and importin-alpha and -beta are re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran from importin. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus. Mediates autonomously the nuclear import of ribosomal proteins RPL23A, RPS7 and RPL5. Binds to a beta-like import receptor binding (BIB) domain of RPL23A. In association with IPO7 mediates the nuclear import of H1 histone. In vitro, mediates nuclear import of H2A, H2B, H3 and H4 histones. In case of HIV-1 infection, binds and mediates the nuclear import of HIV-1 Rev. Imports SNAI1 and PRKCI into the nucleus..
Protein Sequence MELITILEKTVSPDRLELEAAQKFLERAAVENLPTFLVELSRVLANPGNSQVARVAAGLQIKNSLTSKDPDIKAQYQQRWLAIDANARREVKNYVLQTLGTETYRPSSASQCVAGIACAEIPVNQWPELIPQLVANVTNPNSTEHMKESTLEAIGYICQDIDPEQLQDKSNEILTAIIQGMRKEEPSNNVKLAATNALLNSLEFTKANFDKESERHFIMQVVCEATQCPDTRVRVAALQNLVKIMSLYYQYMETYMGPALFAITIEAMKSDIDEVALQGIEFWSNVCDEEMDLAIEASEAAEQGRPPEHTSKFYAKGALQYLVPILTQTLTKQDENDDDDDWNPCKAAGVCLMLLATCCEDDIVPHVLPFIKEHIKNPDWRYRDAAVMAFGCILEGPEPSQLKPLVIQAMPTLIELMKDPSVVVRDTAAWTVGRICELLPEAAINDVYLAPLLQCLIEGLSAEPRVASNVCWAFSSLAEAAYEAADVADDQEEPATYCLSSSFELIVQKLLETTDRPDGHQNNLRSSAYESLMEIVKNSAKDCYPAVQKTTLVIMERLQQVLQMESHIQSTSDRIQFNDLQSLLCATLQNVLRKVQHQDALQISDVVMASLLRMFQSTAGSGGVQEDALMAVSTLVEVLGGEFLKYMEAFKPFLGIGLKNYAEYQVCLAAVGLVGDLCRALQSNIIPFCDEVMQLLLENLGNENVHRSVKPQILSVFGDIALAIGGEFKKYLEVVLNTLQQASQAQVDKSDYDMVDYLNELRESCLEAYTGIVQGLKGDQENVHPDVMLVQPRVEFILSFIDHIAGDEDHTDGVVACAAGLIGDLCTAFGKDVLKLVEARPMIHELLTEGRRSKTNKAKTLATWATKELRKLKNQA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MELITILE
-------CCCCHHHH
9.4919413330
1Sulfoxidation-------MELITILE
-------CCCCHHHH
9.4928183972
5Phosphorylation---MELITILEKTVS
---CCCCHHHHHCCC
31.9420068231
10PhosphorylationLITILEKTVSPDRLE
CCHHHHHCCCCCHHH
19.4823927012
12PhosphorylationTILEKTVSPDRLELE
HHHHHCCCCCHHHHH
26.7223927012
15MethylationEKTVSPDRLELEAAQ
HHCCCCCHHHHHHHH
33.18115481407
23UbiquitinationLELEAAQKFLERAAV
HHHHHHHHHHHHHHH
47.3821890473
232-HydroxyisobutyrylationLELEAAQKFLERAAV
HHHHHHHHHHHHHHH
47.38-
23UbiquitinationLELEAAQKFLERAAV
HHHHHHHHHHHHHHH
47.3821890473
23AcetylationLELEAAQKFLERAAV
HHHHHHHHHHHHHHH
47.3821466224
23UbiquitinationLELEAAQKFLERAAV
HHHHHHHHHHHHHHH
47.3821890473
41PhosphorylationPTFLVELSRVLANPG
CHHHHHHHHHHCCCC
13.5621712546
46UbiquitinationELSRVLANPGNSQVA
HHHHHHCCCCCHHHH
40.63-
50PhosphorylationVLANPGNSQVARVAA
HHCCCCCHHHHHHHH
31.7621712546
61UbiquitinationRVAAGLQIKNSLTSK
HHHHCCEECCCCCCC
5.69-
62UbiquitinationVAAGLQIKNSLTSKD
HHHCCEECCCCCCCC
27.7621906983
62UbiquitinationVAAGLQIKNSLTSKD
HHHCCEECCCCCCCC
27.7621890473
62UbiquitinationVAAGLQIKNSLTSKD
HHHCCEECCCCCCCC
27.7621890473
66AcetylationLQIKNSLTSKDPDIK
CEECCCCCCCCCCHH
33.29-
66UbiquitinationLQIKNSLTSKDPDIK
CEECCCCCCCCCCHH
33.29-
68UbiquitinationIKNSLTSKDPDIKAQ
ECCCCCCCCCCHHHH
68.96-
682-HydroxyisobutyrylationIKNSLTSKDPDIKAQ
ECCCCCCCCCCHHHH
68.96-
68AcetylationIKNSLTSKDPDIKAQ
ECCCCCCCCCCHHHH
68.9626051181
68SuccinylationIKNSLTSKDPDIKAQ
ECCCCCCCCCCHHHH
68.9623954790
73UbiquitinationTSKDPDIKAQYQQRW
CCCCCCHHHHHHHHH
36.50-
732-HydroxyisobutyrylationTSKDPDIKAQYQQRW
CCCCCCHHHHHHHHH
36.50-
73AcetylationTSKDPDIKAQYQQRW
CCCCCCHHHHHHHHH
36.5026051181
76PhosphorylationDPDIKAQYQQRWLAI
CCCHHHHHHHHHHHH
16.0919702290
170PhosphorylationPEQLQDKSNEILTAI
HHHHHHHHHHHHHHH
48.2420068231
175PhosphorylationDKSNEILTAIIQGMR
HHHHHHHHHHHHHHC
22.8220068231
181SulfoxidationLTAIIQGMRKEEPSN
HHHHHHHHCCCCCCC
2.9521406390
191AcetylationEEPSNNVKLAATNAL
CCCCCHHHHHHHHHH
34.2325953088
191UbiquitinationEEPSNNVKLAATNAL
CCCCCHHHHHHHHHH
34.23-
201PhosphorylationATNALLNSLEFTKAN
HHHHHHHHHHHHHHC
29.2824719451
206UbiquitinationLNSLEFTKANFDKES
HHHHHHHHHCCCCHH
46.8021906983
2062-HydroxyisobutyrylationLNSLEFTKANFDKES
HHHHHHHHHCCCCHH
46.80-
206UbiquitinationLNSLEFTKANFDKES
HHHHHHHHHCCCCHH
46.8021890473
206UbiquitinationLNSLEFTKANFDKES
HHHHHHHHHCCCCHH
46.8021890473
211AcetylationFTKANFDKESERHFI
HHHHCCCCHHHHHHH
60.0319608861
211UbiquitinationFTKANFDKESERHFI
HHHHCCCCHHHHHHH
60.0319608861
226PhosphorylationMQVVCEATQCPDTRV
HHHHHHHHCCCCHHH
14.38-
231AcetylationEATQCPDTRVRVAAL
HHHCCCCHHHHHHHH
19.06-
231UbiquitinationEATQCPDTRVRVAAL
HHHCCCCHHHHHHHH
19.06-
246PhosphorylationQNLVKIMSLYYQYME
HHHHHHHHHHHHHHH
19.3825867546
248PhosphorylationLVKIMSLYYQYMETY
HHHHHHHHHHHHHHH
4.9225867546
249PhosphorylationVKIMSLYYQYMETYM
HHHHHHHHHHHHHHH
9.8425867546
251PhosphorylationIMSLYYQYMETYMGP
HHHHHHHHHHHHHHH
4.8425867546
254PhosphorylationLYYQYMETYMGPALF
HHHHHHHHHHHHHHH
11.4125867546
255PhosphorylationYYQYMETYMGPALFA
HHHHHHHHHHHHHHH
6.1825867546
264PhosphorylationGPALFAITIEAMKSD
HHHHHHHHHHHHHCC
14.8825867546
372UbiquitinationPHVLPFIKEHIKNPD
HHHHHHHHHHCCCCC
43.55-
376UbiquitinationPFIKEHIKNPDWRYR
HHHHHHCCCCCCHHH
65.4221890473
376AcetylationPFIKEHIKNPDWRYR
HHHHHHCCCCCCHHH
65.4225953088
376UbiquitinationPFIKEHIKNPDWRYR
HHHHHHCCCCCCHHH
65.4221890473
376UbiquitinationPFIKEHIKNPDWRYR
HHHHHHCCCCCCHHH
65.4221890473
392UbiquitinationAAVMAFGCILEGPEP
HHHHHHHHHHCCCCH
2.31-
396UbiquitinationAFGCILEGPEPSQLK
HHHHHHCCCCHHHCH
28.55-
404UbiquitinationPEPSQLKPLVIQAMP
CCHHHCHHHHHHHHH
40.21-
421PhosphorylationIELMKDPSVVVRDTA
HHHHCCCCEEECCCH
37.3623403867
448PhosphorylationEAAINDVYLAPLLQC
HHHHCCHHHHHHHHH
10.46-
449UbiquitinationAAINDVYLAPLLQCL
HHHCCHHHHHHHHHH
3.88-
506UbiquitinationLSSSFELIVQKLLET
HHHHHHHHHHHHHHC
2.13-
513PhosphorylationIVQKLLETTDRPDGH
HHHHHHHCCCCCCCC
33.6924275569
526PhosphorylationGHQNNLRSSAYESLM
CCCCCHHHHHHHHHH
23.6128152594
527PhosphorylationHQNNLRSSAYESLME
CCCCHHHHHHHHHHH
28.5628152594
529PhosphorylationNNLRSSAYESLMEIV
CCHHHHHHHHHHHHH
14.1628796482
531PhosphorylationLRSSAYESLMEIVKN
HHHHHHHHHHHHHHH
21.9728152594
533SulfoxidationSSAYESLMEIVKNSA
HHHHHHHHHHHHHCH
4.6230846556
537UbiquitinationESLMEIVKNSAKDCY
HHHHHHHHHCHHHCH
51.3421906983
537UbiquitinationESLMEIVKNSAKDCY
HHHHHHHHHCHHHCH
51.3421890473
537AcetylationESLMEIVKNSAKDCY
HHHHHHHHHCHHHCH
51.3425953088
537UbiquitinationESLMEIVKNSAKDCY
HHHHHHHHHCHHHCH
51.3421890473
539PhosphorylationLMEIVKNSAKDCYPA
HHHHHHHCHHHCHHH
30.8624275569
541UbiquitinationEIVKNSAKDCYPAVQ
HHHHHCHHHCHHHHH
48.4221906983
5412-HydroxyisobutyrylationEIVKNSAKDCYPAVQ
HHHHHCHHHCHHHHH
48.42-
544PhosphorylationKNSAKDCYPAVQKTT
HHCHHHCHHHHHHHH
12.3620068231
549UbiquitinationDCYPAVQKTTLVIME
HCHHHHHHHHHHHHH
36.5621906983
564SulfoxidationRLQQVLQMESHIQST
HHHHHHHHHHHHCCC
5.0921406390
565UbiquitinationLQQVLQMESHIQSTS
HHHHHHHHHHHCCCC
26.63-
566PhosphorylationQQVLQMESHIQSTSD
HHHHHHHHHHCCCCC
22.1322210691
585UbiquitinationNDLQSLLCATLQNVL
HHHHHHHHHHHHHHH
3.09-
587PhosphorylationLQSLLCATLQNVLRK
HHHHHHHHHHHHHHH
28.07-
594UbiquitinationTLQNVLRKVQHQDAL
HHHHHHHHCCCCCHH
41.93-
614SulfoxidationVMASLLRMFQSTAGS
HHHHHHHHHHHCCCC
3.4630846556
617PhosphorylationSLLRMFQSTAGSGGV
HHHHHHHHCCCCCCC
14.6822210691
618PhosphorylationLLRMFQSTAGSGGVQ
HHHHHHHCCCCCCCH
25.0122210691
621PhosphorylationMFQSTAGSGGVQEDA
HHHHCCCCCCCHHHH
29.8823532336
630SulfoxidationGVQEDALMAVSTLVE
CCHHHHHHHHHHHHH
3.5730846556
632UbiquitinationQEDALMAVSTLVEVL
HHHHHHHHHHHHHHH
2.53-
646PhosphorylationLGGEFLKYMEAFKPF
HCHHHHHHHHHHCCH
11.4420860994
651UbiquitinationLKYMEAFKPFLGIGL
HHHHHHHCCHHCCCC
41.7421890473
651UbiquitinationLKYMEAFKPFLGIGL
HHHHHHHCCHHCCCC
41.7421890473
651AcetylationLKYMEAFKPFLGIGL
HHHHHHHCCHHCCCC
41.7426051181
651UbiquitinationLKYMEAFKPFLGIGL
HHHHHHHCCHHCCCC
41.7421890473
690AcetylationSNIIPFCDEVMQLLL
CCCHHHHHHHHHHHH
52.48-
690UbiquitinationSNIIPFCDEVMQLLL
CCCHHHHHHHHHHHH
52.48-
710UbiquitinationENVHRSVKPQILSVF
CCHHHCCCHHHHHHH
32.2421906983
714UbiquitinationRSVKPQILSVFGDIA
HCCCHHHHHHHHHHH
2.77-
722AcetylationSVFGDIALAIGGEFK
HHHHHHHHHHCCHHH
3.49-
722UbiquitinationSVFGDIALAIGGEFK
HHHHHHHHHHCCHHH
3.49-
726UbiquitinationDIALAIGGEFKKYLE
HHHHHHCCHHHHHHH
30.93-
730UbiquitinationAIGGEFKKYLEVVLN
HHCCHHHHHHHHHHH
61.4621890473
730UbiquitinationAIGGEFKKYLEVVLN
HHCCHHHHHHHHHHH
61.4621890473
730UbiquitinationAIGGEFKKYLEVVLN
HHCCHHHHHHHHHHH
61.4621890473
738PhosphorylationYLEVVLNTLQQASQA
HHHHHHHHHHHHHHH
23.06-
743PhosphorylationLNTLQQASQAQVDKS
HHHHHHHHHHCCCCC
23.01-
750PhosphorylationSQAQVDKSDYDMVDY
HHHCCCCCHHHHHHH
36.6229978859
752PhosphorylationAQVDKSDYDMVDYLN
HCCCCCHHHHHHHHH
17.0328796482
754SulfoxidationVDKSDYDMVDYLNEL
CCCCHHHHHHHHHHH
1.6930846556
757PhosphorylationSDYDMVDYLNELRES
CHHHHHHHHHHHHHH
10.46-
777UbiquitinationTGIVQGLKGDQENVH
HHHHHHHCCCCCCCC
68.2321906983
788SulfoxidationENVHPDVMLVQPRVE
CCCCCCEEEECCCHH
3.8521406390
835AcetylationAFGKDVLKLVEARPM
HHCHHHHHHHHHHHH
50.7819608861
835UbiquitinationAFGKDVLKLVEARPM
HHCHHHHHHHHHHHH
50.7821890473
8352-HydroxyisobutyrylationAFGKDVLKLVEARPM
HHCHHHHHHHHHHHH
50.78-
835MalonylationAFGKDVLKLVEARPM
HHCHHHHHHHHHHHH
50.7826320211
835UbiquitinationAFGKDVLKLVEARPM
HHCHHHHHHHHHHHH
50.7821890473
835UbiquitinationAFGKDVLKLVEARPM
HHCHHHHHHHHHHHH
50.7821890473
842SulfoxidationKLVEARPMIHELLTE
HHHHHHHHHHHHHHC
3.9921406390
853PhosphorylationLLTEGRRSKTNKAKT
HHHCCCCCCCCHHHH
42.3322817900
855PhosphorylationTEGRRSKTNKAKTLA
HCCCCCCCCHHHHHH
43.1022817900
859UbiquitinationRSKTNKAKTLATWAT
CCCCCHHHHHHHHHH
45.76-
867AcetylationTLATWATKELRKLKN
HHHHHHHHHHHHHHH
47.1819608861
867UbiquitinationTLATWATKELRKLKN
HHHHHHHHHHHHHHH
47.1821890473
8672-HydroxyisobutyrylationTLATWATKELRKLKN
HHHHHHHHHHHHHHH
47.18-
867MalonylationTLATWATKELRKLKN
HHHHHHHHHHHHHHH
47.1826320211
867UbiquitinationTLATWATKELRKLKN
HHHHHHHHHHHHHHH
47.1821890473
867UbiquitinationTLATWATKELRKLKN
HHHHHHHHHHHHHHH
47.1821890473
871UbiquitinationWATKELRKLKNQA--
HHHHHHHHHHHCC--
76.16-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of IMB1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of IMB1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of IMB1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
SRBP2_HUMANSREBF2physical
11283257
IMA1_HUMANKPNA2physical
11283257
NU153_HUMANNUP153physical
10202161
NUP50_HUMANNUP50physical
12176322
SMAD3_HUMANSMAD3physical
10846168
SMAD4_HUMANSMAD4physical
10846168
IPO7_HUMANIPO7physical
9214382
IPO8_HUMANIPO8physical
9214382
NU153_HUMANNUP153physical
10749866
MTG8_HUMANRUNX1T1physical
10951564
NUP62_HUMANNUP62physical
11266456
NUP54_HUMANNUP54physical
11266456
NU153_HUMANNUP153physical
11266456
RBP2_HUMANRANBP2physical
11266456
RAN_HUMANRANphysical
9135132
NUP62_HUMANNUP62physical
9102465
NTF2_HUMANNUTF2physical
9102465
IMA5_HUMANKPNA1physical
9102465
RAN_HUMANRANphysical
9102465
RANG_HUMANRANBP1physical
10779340
RAN_HUMANRANphysical
10779340
NUP98_HUMANNUP98physical
9144189
SRY_HUMANSRYphysical
15297880
RCC1_HUMANRCC1physical
17855385
RAN_HUMANRANphysical
20658144
RANG_HUMANRANBP1physical
20658144
NU153_HUMANNUP153physical
20658144
IMB1_HUMANKPNB1physical
21832065
AMFR_HUMANAMFRphysical
21832065
DERL1_HUMANDERL1physical
21832065
SELS_HUMANVIMPphysical
21832065
CUL4B_HUMANCUL4Bphysical
19801544
RAN_HUMANRANphysical
10037787
RANG_HUMANRANBP1physical
10037787
EXO1_HUMANEXO1physical
22222486
TBA1A_HUMANTUBA1Aphysical
21278340
RBP2_HUMANRANBP2physical
8909533
RANG_HUMANRANBP1physical
8909533
RAN_HUMANRANphysical
8909533
PIAS4_HUMANPIAS4physical
15383276
PTN_HUMANPTNphysical
15383276
NXF1_HUMANNXF1physical
21965294
DCAF8_HUMANDCAF8physical
22500989
RAE1L_HUMANRAE1physical
15851029
RAN_HUMANRANphysical
9045717
RANG_HUMANRANBP1physical
9045717
RAN_HUMANRANphysical
22939629
IPO5_HUMANIPO5physical
22939629
IPO9_HUMANIPO9physical
22939629
ERBB2_HUMANERBB2physical
16314522
RASF5_HUMANRASSF5physical
23538446
RAN_HUMANRANphysical
9214382
NU100_YEASTNUP100physical
25562883
NU116_YEASTNUP116physical
25562883
NUP98_HUMANNUP98physical
25562883
NU98B_ARATHAT1G59660physical
25562883
NUP98_CAEELnpp-10physical
25562883
SMAP_HUMANC11orf58physical
26344197
XPO2_HUMANCSE1Lphysical
26344197
EXOS2_HUMANEXOSC2physical
26344197
IPO4_HUMANIPO4physical
26344197
IPO8_HUMANIPO8physical
26344197
IPO9_HUMANIPO9physical
26344197
NUCL_HUMANNCLphysical
26344197
NUP98_HUMANNUP98physical
26344197
RAN_HUMANRANphysical
26344197
RNBP6_HUMANRANBP6physical
26344197
SF3B3_HUMANSF3B3physical
26344197
AL3A2_HUMANALDH3A2physical
26496610
RCC1_HUMANRCC1physical
26496610
ERF1_HUMANETF1physical
26496610
GLE1_HUMANGLE1physical
26496610
ECHB_HUMANHADHBphysical
26496610
SP110_HUMANSP110physical
26496610
KIFC1_HUMANKIFC1physical
26496610
IMA5_HUMANKPNA1physical
26496610
IMA1_HUMANKPNA2physical
26496610
IMA4_HUMANKPNA3physical
26496610
IMA3_HUMANKPNA4physical
26496610
NSF_HUMANNSFphysical
26496610
NUP88_HUMANNUP88physical
26496610
NUP98_HUMANNUP98physical
26496610
RAN_HUMANRANphysical
26496610
RANG_HUMANRANBP1physical
26496610
RBP2_HUMANRANBP2physical
26496610
RAGP1_HUMANRANGAP1physical
26496610
TAF4B_HUMANTAF4Bphysical
26496610
TAF11_HUMANTAF11physical
26496610
UBC9_HUMANUBE2Iphysical
26496610
SUMO1_HUMANSUMO1physical
26496610
R113A_HUMANRNF113Aphysical
26496610
NU214_HUMANNUP214physical
26496610
AAAS_HUMANAAASphysical
26496610
RAE1L_HUMANRAE1physical
26496610
CCNK_HUMANCCNKphysical
26496610
NU155_HUMANNUP155physical
26496610
NUP93_HUMANNUP93physical
26496610
DLGP5_HUMANDLGAP5physical
26496610
RUSC2_HUMANRUSC2physical
26496610
MED24_HUMANMED24physical
26496610
NU153_HUMANNUP153physical
26496610
NXF1_HUMANNXF1physical
26496610
IPO7_HUMANIPO7physical
26496610
NUP50_HUMANNUP50physical
26496610
S27A2_HUMANSLC27A2physical
26496610
NUPL2_HUMANNUPL2physical
26496610
NU205_HUMANNUP205physical
26496610
PO210_HUMANNUP210physical
26496610
NU160_HUMANNUP160physical
26496610
NEMP1_HUMANTMEM194Aphysical
26496610
NU188_HUMANNUP188physical
26496610
IMA7_HUMANKPNA6physical
26496610
VIR_HUMANKIAA1429physical
26496610
QCR9_HUMANUQCR10physical
26496610
SENP1_HUMANSENP1physical
26496610
CERS2_HUMANCERS2physical
26496610
NUSAP_HUMANNUSAP1physical
26496610
TM214_HUMANTMEM214physical
26496610
CEP55_HUMANCEP55physical
26496610
NSMA3_HUMANSMPD4physical
26496610
NDC1_HUMANNDC1physical
26496610
NU133_HUMANNUP133physical
26496610
NU107_HUMANNUP107physical
26496610
THOC2_HUMANTHOC2physical
26496610
CHD8_HUMANCHD8physical
26496610
NUP37_HUMANNUP37physical
26496610
ZC3HE_HUMANZC3H14physical
26496610
NUP85_HUMANNUP85physical
26496610
SEH1_HUMANSEH1Lphysical
26496610
PKHA8_HUMANPLEKHA8physical
26496610
TM209_HUMANTMEM209physical
26496610
SPB12_HUMANSERPINB12physical
26496610
YTDC1_HUMANYTHDC1physical
26496610
CMTD1_HUMANCOMTD1physical
26496610
NUP53_HUMANNUP35physical
26496610
CDCA2_HUMANCDCA2physical
26496610
NUP43_HUMANNUP43physical
26496610
RGPD8_HUMANRGPD8physical
26496610
STOM_HUMANSTOMphysical
27173435

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of IMB1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY.
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-211; LYS-835 AND LYS-867,AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-12, AND MASSSPECTROMETRY.
Ubiquitylation
ReferencePubMed
"Tryptic digestion of ubiquitin standards reveals an improved strategyfor identifying ubiquitinated proteins by mass spectrometry.";
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.;
Proteomics 7:868-874(2007).
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-206 AND LYS-211, AND MASSSPECTROMETRY.

TOP